Bayer gets USFDA Breakthrough Therapy designation for BAY 2927088 for non-small cell lung cancer harboring HER2 activating mutations Written By Ruchika Sharma29 Feb 2024 1:30 PM ISTBAY 2927088 was derived from Bayer's long-standing strategic research alliance with the Broad Institute of MIT and Harvard in Cambridge, MA, USA.
Scientists develop simple blood test to quickly diagnose sarcoidosis Written By Dr. Kamal Kant Kohli29 Feb 2024 4:00 AM ISTA research project supported by the National Institutes of Health has developed a tool to rapidly and inexpensively diagnose sarcoidosis, a chronic...
What is effect of low-dose cadmium on airway epithelial cells in COPD patients? Written By Dr. Kamal Kant Kohli28 Feb 2024 3:00 AM ISTCigarette smoke exposure is associated with the development and severity of chronic obstructive pulmonary disease, or COPD, which is the third leading...
Repeat CT-guided biopsy Ok, trial does not support PET-CT in diagnostic pathway of non-diagnostic pleural biopsy Written By Dr. Shravani Dali27 Feb 2024 5:00 AM ISTRepeat CT-guided biopsy Ok, trial does not support PET-CT in diagnostic pathway of non-diagnostic pleural biopsy suggests a new study published in the...
Female reproductive factors influence chronic obstructive pulmonary disease risk Jacinthlyn Sylvia26 Feb 2024 8:15 PM ISTA recent study published in the BMJ Thorax Journal highlight the potential link between female reproductive factors and the development of...
Merck gets positive EMA Committee opinion for Keytruda, chemotherapy combo for Resectable non-small cell lung cancer Written By Ruchika Sharma26 Feb 2024 2:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Medicines Agency's Committee for Medicinal...
Age when periods first start and early menopause linked to heightened COPD risk Written By Dr. Kamal Kant Kohli26 Feb 2024 3:00 AM ISTA range of reproductive factors, including age when periods first start and an early menopause, are all linked to a heightened risk of COPD-the...
India implementing largest digital programme for TB surveillance and monitoring Written By Kajal Rajput25 Feb 2024 9:30 AM ISTNew Delhi: India has made ''significant progress'' in scaling up molecular diagnostics and is implementing the largest digital programme for TB...
Nintedanib Reveals Remarkable Efficacy in Alleviating Progressive Pulmonary Fibrosis Symptoms Written By Dr.Niharika Harsha B23 Feb 2024 6:30 PM ISTIn the groundbreaking INBUILD trial, researchers discovered that nintedanib can significantly improve the lives of patients suffering from...
New zinc discovery offers promise for cystic fibrosis patients Written By Anshika Mishra23 Feb 2024 5:15 PM ISTResearchers from the University of Queensland have discovered a fault in the bacteria-killing function of immune cells in people with Cystic Fibrosis...
Dupixent application accepted for priority review by USFDA for COPD with type 2 inflammation Written By Ruchika Sharma23 Feb 2024 4:30 PM ISTParis: Sanofi has announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License...
Automatic mechanical ventilation feasible and comparable to manual ventilation method during CPR: Study Written By Dr Riya Dave22 Feb 2024 6:15 PM ISTThe effectiveness of mechanical ventilation as a replacement for manual bag ventilation during cardiopulmonary resuscitation (CPR) remains uncertain....
